Cardiovascular Risk Stratification In Familial Hypercholesterolaemia. Familial hypercholesterolaemia is relatively common, but is often underdiagnosed and undertreated. 1,2 however, ascvd risk in fh patients varies greatly, and better understanding this spectrum of risk may allow for tailoring treatment especially regarding the need for a pcsk9 inhibitor.
A prior cardiovascular event or overt diabetic nephropathy. The association between cardiovascular risk factors and prevalent cvd was examined in a cross‐sectional study in order to elucidate their contribution to atherogenesis. Notwithstanding an overall reduction in coronary heart disease mortality by 37% with statin therapy, the excess standardised mortality ratio in patients receiving.
Cardiovascular risk stratification in familial hypercholesterolaemia.
De sauvage np, defesche j, buirma r, hutten b, lansberg p, kastelein j. Cardiovascular risk stratification in familial hypercholesterolaemia. De sauvage np, defesche j, buirma r, hutten b, lansberg p, kastelein j. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: